With more than 10,500 global members, SOHO is poised to educate hematologic oncologists from every corridor of the Earth. The SOHO Ambassador Program powers this reach. Read more about this program here: sohoinsider.com/news/soho-gl...

FDA authorizes new companion diagnostic for KMTA-rearranged acute leukemia sohoinsider.com/leukemia/fda...

ICYMI: FDA grants Orphan Drug Designation for AK117 (ligufalimab) sohoinsider.com/news/ak117-l...

The next breakthrough starts here 🔨. Join us on November 20 for a one-day, virtual meeting, featuring leaders in #hemonc. Save your seat by registering today at soho.click/SBBC. Free for members; $50 for non-SOHO members.

ICYMI: Watch Muhammad Bilal Abid, MD, MS, on protecting patients with blood cancers from COVID-19 vimeo.com/1114018882?r...

ICYMI: Addition of lisaftoclax to myeloma regimens improved depth of response.

Drs. Melody, Phillips talk glofitamab in MCL our new SOHO Insider podcast. sohoinsider.com/lymphoma/drs...

Check out our latest SOHO Insider print issue. We feature a story on radiotherapy in blood cancers, an editorial from Dr. Jerry Radich, and an interview with Dr. Alice Mims. sohoinsider.com/current-issue/

B-, T-cell lymphoma diagnostic test launched at #SOHO2025 sohoinsider.com/meetings-con...

Dr. Abid, a clinician-scientist at the University of Texas Health Science Center in Houston, outlined the heightened risks COVID-19 poses for immunocompromised patients with blood cancer. sohoinsider.com/lymphoma/dr-...

Linvoseltamab shows strong 1st results in high-risk smoldering myeloma sohoinsider.com/multiple-mye...

ICYMI: Muhammad Bilal Abid, MD, MS, on protecting patients with blood cancers from COVID-19 sohoinsider.com/lymphoma/dr-...

Interim analysis shows promise in belantamab-based maintenance in high-risk multiple myeloma sohoinsider.com/meetings-con...

Daratumumab raises early infection risk in myeloma sohoinsider.com/multiple-mye... #IMS25 #IMS2025

Phase 1 study shows promising results for off-the-shelf trispecific antibody for myeloma.

Should heart health get more attention in WM patients? sohoinsider.com/news/wm-mort...

Simu Du, MD, an internal medicine resident at the Jacobi Medical Center, affiliated with Albert Einstein College of Medicine in the Bronx, shares findings on CAR-T therapy for blood cancers.

Elranatamb, daratumumab, lenalidomide combo induces early responses in newly diagnosed MM.

Belantamab mafodotin, pomalidomide, dexamethasone combo a “potential standard of care” for relapsed/refractory MM.

GLP-1a therapy tied to better survival, fewer complications in #PV. #SOHO2025 #awardwinners sohoinsider.com/meetings-con...

Addition of mezigdomide to myeloma treatment regimens shows promise for relapsed/refractory disease.

Phase 3 study shows benefits of early intervention with daratumumab monotherapy for high-risk SMM.

Addition of lisaftoclax to myeloma regimens improved depth of response sohoinsider.com/meetings-con...

You're not you when your hungry...go visit our break stations for the perfect snack! #SOHO2025

Getting hangry? Now is the perfect time for you to head to one of the break stations for a quick bite! #SOHO2025

Break Time: Go visit our Supporters in the Exhibit Hall! #SOHO2025

Need a quick snack? Head to one of our break stations in the Exhibit Hall to refuel with a delicious treat before the next session! #SOHO2025

The wait is over - #SOHO2025 is finally here! 🎉 👉 Badge pickup is open today from 3-7 PM and tomorrow starting at 6:30 AM on the 3rd Level of the GRB Convention Center. See you soon! Not in Houston? You can still attend virtually! Register at soho.click/2025

Download the SOHO365 mobile app before #SOHO2025 to join live polls and Q&As during the sessions, whether you're in Houston or tuning in virtually, you will want the app! www.sohoonline.org/SOHO2025/SOH...

This year, #SOHO2025 will have several sessions discussing #AI in #hemonc. We highlight the sessions in this article: sohoinsider.com/meetings-con... Remember to download the SOHO365 mobile app to take part in polls and live Q&A. There is still time to register virtually at soho.click/2025.

This year is our biggest SOHO yet. With more than 1,000 abstracts at #SOHO2025, there’s something for everyone, no matter where you are in your hematology career. soho.click/2025

Not traveling to Houston this year? You can still be part of #SOHO2025! 🖥 Join us virtually for the latest updates in leukemias, lymphomas, myeloma, MPNs, cellular therapy & more. ☑️ Earn CME/CE credit ☑️ Participate in live Q&As ☑️ Replay sessions on-demand Register now ➡️ soho.click/2025

As we go into #SOHO2025, our Executive Director Janet Cesak writes that the "Society's success is the result of the dedication and vision of our members, faculty, and partners. Thank you for being part of this extraordinary journey." Register today: soho.click/2025 sohoinsider.com/society-upda...

Poor outcomes in a subgroup of follicular lymphoma prompts need for personalized treatment approach sohoinsider.com/lymphoma/ind...

Wait a second — how did THEY get the #SOHO2025 Annual Meeting Daily Edition before anyone else? You’ll get yours the right way register 👉 soho.click/2025 virtual registration is only $84 for #SOHO members.

Oral decitabine and cedazuridine combo shows promise as post-HSCT option sohoinsider.com/leukemia/acu...

We are less than two weeks away from #SOHO2025. Register now at soho.click/2025

New SOHO Insider podcast with Drs. Callie Coombs & host Susan O'Brien on CLL trial updates including GAIA/CLL13 and AMPLIFY trials sohoinsider.com/news/soho-in...

Whether in Houston or your home office, you can still be a part of #SOHO2025! Join us Sept. 3-6 to hear the latest advances in #HemOnc from global experts. Attend in person in Houston or join virtually for full access to live sessions, Q&A & CME credit from anywhere! Register now👉 soho.click/2025

SOHO EAGLE program takes off, expanding access to education globally #SOHO2025 sohoinsider.com/society-upda...

New blood test diagnoses #MM noninvasively sohoinsider.com/multiple-mye...

From the tropics to the tundra, across oceans and continents, no matter where, you can attend #SOHO2025 virtually. Register at soho.click/2025 to secure your spot today!

If you haven't already, check out our Ask the Expert forum with @drhkantarjian.bsky.social Latest question comes from Dr. Keisuke Kidoguchi from Saga University in Japan. Learn how to access the forum here: sohoinsider.com/ask-the-expe...

What do the real-world data show on luspatercept in LR-MDS? Find out in this video clip from Dr. Idoroenyi Amanam sohoinsider.com/meetings-con...

Real-world study: treatment post-relapse improves survival outcomes in patients with AML or MDS sohoinsider.com/leukemia/acu...

New AI tool ‘DeepHeme’ improves blood cancer diagnosis sohoinsider.com/news/new-ai-...

Don’t be the one hearing about it later—be there! Register for #SOHO2025 today at soho.click/2025.

FDA approves biosimilar tocilizumab‑anoh for treatment of CRS sohoinsider.com/news/fda-app...

Insider lymphoma podcast with host Megan Melody, MD and guest Anca Prica, MD sohoinsider.com/lymphoma/ins...

ICYMI: EC approves obe-cel for relapsed or refractory B-ALL sohoinsider.com/news/obe-cel...